SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.911
AS - Asia 6.027
EU - Europa 3.363
SA - Sud America 1.277
Continente sconosciuto - Info sul continente non disponibili 540
AF - Africa 235
OC - Oceania 41
Totale 18.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.401
IT - Italia 1.687
SG - Singapore 1.596
BD - Bangladesh 1.539
BR - Brasile 946
HK - Hong Kong 703
CN - Cina 702
VN - Vietnam 630
NL - Olanda 356
CA - Canada 317
FR - Francia 200
DE - Germania 197
JP - Giappone 180
GB - Regno Unito 170
IN - India 147
FI - Finlandia 124
AR - Argentina 111
RU - Federazione Russa 93
MX - Messico 76
ZA - Sudafrica 74
ES - Italia 72
EC - Ecuador 71
UA - Ucraina 71
ID - Indonesia 67
BE - Belgio 58
IQ - Iraq 56
AE - Emirati Arabi Uniti 55
PL - Polonia 55
TR - Turchia 51
AT - Austria 47
PT - Portogallo 47
PK - Pakistan 46
CO - Colombia 41
EG - Egitto 41
JM - Giamaica 39
AU - Australia 37
SE - Svezia 34
HU - Ungheria 32
VE - Venezuela 32
MY - Malesia 31
TW - Taiwan 30
IE - Irlanda 29
MA - Marocco 28
PH - Filippine 27
UZ - Uzbekistan 26
CL - Cile 24
SA - Arabia Saudita 24
PY - Paraguay 21
TN - Tunisia 21
CR - Costa Rica 19
CH - Svizzera 16
PE - Perù 16
KE - Kenya 15
NP - Nepal 14
DZ - Algeria 13
KZ - Kazakistan 13
NO - Norvegia 13
ET - Etiopia 12
IL - Israele 11
NI - Nicaragua 11
BO - Bolivia 10
HN - Honduras 10
JO - Giordania 10
LT - Lituania 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 8
OM - Oman 8
CZ - Repubblica Ceca 7
IR - Iran 7
RO - Romania 7
PA - Panama 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AM - Armenia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 5
NG - Nigeria 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
BB - Barbados 4
BY - Bielorussia 4
GT - Guatemala 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
PS - Palestinian Territory 4
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
LY - Libia 3
PR - Porto Rico 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CD - Congo 2
Totale 17.817
Salva come PNG Salva come JPEG
Città #
Ashburn 907
San Jose 868
Singapore 825
Hong Kong 696
New York 542
Council Bluffs 412
Los Angeles 302
Dallas 291
Ho Chi Minh City 207
Beijing 206
Tokyo 169
Hanoi 163
Milan 154
Chicago 139
Santa Clara 128
Buffalo 121
Rome 120
Amsterdam 97
Bologna 91
Toronto 91
São Paulo 81
Helsinki 73
Lauterbourg 70
Naples 69
Orem 69
Montreal 62
Phoenix 53
Utrecht 53
Atlanta 51
Hefei 48
Warsaw 48
Denver 44
San Francisco 44
Turin 44
Florence 42
Abu Dhabi 39
Quito 39
Groningen 38
Lisbon 38
Mexico City 38
Brooklyn 36
Frankfurt am Main 36
Lappeenranta 36
Bari 34
Da Nang 33
Boston 32
Nuremberg 32
Poplar 32
Figino 31
Haiphong 31
Budapest 30
Houston 30
Palermo 30
Paris 29
Baghdad 28
Barcelona 28
Mulhouse 28
Vancouver 28
Boardman 27
Salt Lake City 27
De Lier 26
Dublin 26
Stockholm 26
Charlotte 25
Seattle 25
Cairo 24
Des Moines 24
Belo Horizonte 23
Dhaka 23
London 23
Rio de Janeiro 23
Taichung 23
Ferrara 22
Miami 22
Tampa 22
Tashkent 22
Curitiba 21
Johannesburg 21
Sydney 21
Pasadena 20
Hải Dương 19
Falkenstein 18
Guayaquil 18
Shanghai 18
Brasília 17
Chennai 17
Kuala Lumpur 17
Madrid 17
Memphis 17
Naaldwijk 17
Philadelphia 17
Hangzhou 16
Jakarta 16
Washington 16
Genoa 15
Guarulhos 15
Kingston 15
Munich 15
Padua 15
Reggio Emilia 15
Totale 8.982
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 1.140
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 460
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 357
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 241
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 201
Desmoteplase 193
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 172
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 169
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 162
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 157
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 148
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 148
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 147
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 137
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 135
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 131
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 127
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 125
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 119
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 117
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 114
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 113
Un caffè tra due amici al bar. L'esame obiettivo neurologico 112
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 111
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 109
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 107
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 107
Treatments in Ischemic Stroke: Current and Future 107
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 106
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 106
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 105
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 104
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 103
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 103
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 102
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 101
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 99
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 99
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 98
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-Analysis 97
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 97
History of stroke 94
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 93
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 92
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 92
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 92
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 91
Medical versus neurosurgical treatment in ICH patients: a single center experience 91
Visual experiences of Blaise Pascal 90
Consensus paper on the management of acute isolated vertigo in the emergency department 90
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 88
History of cardiac embolism 88
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 87
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 87
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 85
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 85
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 85
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 85
Sex-related differences in clinical characteristics, treatment and outcomes in patients with atrial fibrillation and acute ischemic stroke treated with non-vitamin-K antagonists 85
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 84
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 84
Pure sensory syndromes in thalamic stroke 83
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 83
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 83
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 82
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 82
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 81
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 81
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 81
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 81
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 80
Predictors of severe intracerebral hemorrhage expansion 79
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 79
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 78
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 78
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 77
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 75
Anticoagulation After Stroke in Patients With Atrial Fibrillation 75
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 75
The turning point in stroke investigation for neurologists 74
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 74
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 74
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 72
A case of typical headache with an atypical diagnosis 72
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 72
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 72
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 71
Migraine and Cryptogenic Ischemic Stroke 70
A sudden neurological deficit in a patient with endocarditis 70
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 70
Acute stroke symptoms: Do differences exist between sexes? 69
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 69
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 69
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 69
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 67
The concept of ischemic penumbra in acute stroke and therapeutic opportunities 67
Semeiotica e gestione delle urgenze neurologiche 67
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 66
Seasonal variability in spontaneous cervical artery dissection 66
Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis 65
Totale 11.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.271
Totale 72.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 1 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/202614.178 571 675 1.161 1.559 1.337 480 789 616 1.055 1.611 1.988 2.336
2026/20272.051 1.364 687 0 0 0 0 0 0 0 0 0 0
Totale 18.394